Pharmaceuticals and drugs fall into Class 5, one of the largest in terms of registered trademarks – it is among the top 10 fullest classes. Which is why it is so difficult to find names available in this class, especially since in addition to the usual constraints of trademark law (more than 1 phoneme and 1 grapheme difference), come those of national or international regulating authorities [...]
Speculation, one of the primary negative connotations associated with domain names, can take different forms. Let’s take a look at the most common terms to get a better handle the subject: Typosquatting: Hijacking the URLs of high traffic domains, to take advantage of when Web users type-in generic common nouns or typos directly into their browser’s address bar [...]
Who would have imagined that toponyms would be a prime source for creating brand names? Strictly speaking, a toponym is a place name. Quensis has collected more than 1,700,000 different names in its databases, from 215 countries around the world: from the United States to Japan, by way of Kazakhstan, Kiribati and Zimbabwe [...]
The USPTO (the American trademark office) system for protection differs quite appreciably from the practice in so-called Roman law. If we start with the European example, a trademark must be exploited within five years from the date its registration is published [...]
A name only has value if it can be commercially exploited. To be exploited, it must be available, that is, it should not be too similar to any existing trademarks in the field and the countries where it is going to be exploited. Hence the necessity of checking for similarities with live trademarks in the relevant business sector [...]
This year, the month of November saw the number of gTLDs* (.com, .net, .org, etc.) top the 100 million mark, including dot-coms which topped 75 million. Dizzying heights This year, the month of November saw the number of gTLDs* (.com, .net, .org, etc.) top the 100 million mark, including dot-coms which topped 75 million [...]
A recent study by Quensis revealed that in a body of more than 7,525 English monosyllabics, only 18% have names registered identically in Class 38, but 72% are actually unavailable if you look at the names similar within one letter. Add Classes 9 and 42, and the monosyllabics still available drop to 44% identical and 4% similar. In short, there is nothing left [...]
Quensis is a company specialized in name creation. Our specificity is to create names with very strong likelihood
of availability.
Quensis is based on a proprietary technology, unique in the world, which integrates the legal parameter into
the creative process and makes it possible to create names that are commercially exploitable.
Subscribe